The QualityStocks Daily Wednesday, July 25th, 2018

Today's Top 3 StockMarketWatch

QualityStocks (WEYL) +56.67%

TraderPower (TORC) +49.50%

StockMarketWatch (NVRO) +35.71%

The QualityStocks Daily Stock List

ImageWare Systems, Inc. (IWSY)

Pennybuster, PennyStocks24, Wall Street Daily, Wall Street Resources, Greenbackers, Microcapmillionaires, and TaglichBrothers reported previously on ImageWare Systems, Inc. (IWSY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

ImageWare Systems, Inc. is a top developer of mobile and cloud-based multi-modal biometric identity management solutions, providing biometric, secure credential, and law enforcement technologies. The Company’s biometric product line is scalable for global deployment. ImageWare’s biometric product line includes a multi-biometric engine. This engine is hardware and algorithm independent. This allows the enrollment and management of unlimited population sizes. ImageWare Systems is based in San Diego, California.

The Company’s identification products are used to manage and issue secure credentials. This includes national IDs, passports, driver's licenses, smart cards, and access control credentials. Its digital booking products provide law enforcement with integrated mug shot, fingerprint livescan, as well as investigative capabilities.  

ImageWare Systems has its EPI Builder®. This provides the foundation for a multi-modal biometric capture platform that ensures device interoperability and support for centralized and distributed deployment models. Furthermore, products include IWS Biometric Engine®. This is the first and only truly multi-modal, device-and algorithm-independent biometric software platform.

Moreover, ImageWare has its is a highly modular, SOA-based software platform. It delivers a first-class capability to rapidly develop and deploy highly secure, yet flexible standards based identity solutions.

The Company’s next-generation cloud identity management and authentication service is GoMobile Interactive™ (GMI). GMI is a cloud-based, multi-modal biometric mobile identity management solution. GMI is constructed upon the award-winning IWS Biometric Engine® (IWS BE), an SOA based server platform that enables advanced biometric data process and management with ESB connectivity.

ImageWare delivers unique mobile capabilities to the wireless, financial services, and healthcare sectors. The pillphone® enabled by ImageWare’s GoMobile interactive push application platform, is Food and Drug Administration (FDA) cleared. It is the only mobile health management application secured by biometrics. Additionally, the Company has its GoVerifyID solution. GoVerifyID is its patented mobile biometric user authentication solution.

Also, ImageWare Systems has its GoVerifyID® Enterprise Suite, an inventive, multi-modal, multi-factor biometric authentication solution for the enterprise market. GoVerifyID Enterprise Suite is an algorithm-agnostic solution. It is the first ever end-to-end biometric platform, which seamlessly integrates with an enterprise's existing Microsoft infrastructure, providing businesses a turnkey biometric solution for quick deployment in an afternoon or less.

This past June, ImageWare Systems announced that it and Info X Distribution entered into an agreement enabling Info X Distribution to market and resell ImageWare Systems’ GoVerifyID Enterprise Suite and SaaS solutions. Info X Distribution (based in New Jersey) is an international distributor of storage and networking solutions. Its specialty is the distribution of storage, software, and server connectivity of virtualized networks and cloud environments. Info X Distribution provides top-tier solutions to greater than 2,000 VARs, VMware Resellers, Original Equipment Manufacturers (OEMs) and System Integrators.

ImageWare Systems expanded its agreement with Fujitsu to support mobile devices and market the GoVerifyID group of products in Europe, the Middle East, India, Africa, and the Americas. ImageWare has also finalized the integration of biometric identity management and credentialing software into five Alaskan airports. The Company was recognized by CIO Applications as one of the “Top 25 Cyber Security Companies for 2017.”

ImageWare Systems, Inc. (IWSY), closed Wednesday's trading session at $1.155, up 5.00%, on 11,750 volume with 24 trades. The average volume for the last 60 days is 102,954 and the stock's 52-week low/high is $0.8917/$2.24.

GB Sciences, Inc. (GBLX), Money Morning, SeriousTraders, Otcstockexchange, PennyStockInformer, Whisper from Wall Street, CFN Media Group, AllPennyStocks, Stockgoodies, SmallCapVoice, Cannabis Financial Network News, StocksToBuyNow, PennyStockLaboratory, Wall Street Resources, Wall St Report, Pumps and Dumps, and TradeThesePicks reported on GB Sciences, Inc. (GBLX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

GB Sciences, Inc. is a biopharmaceutical Research and Development (R&D) company. Its emphasis is on creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions. GB Sciences is headquartered in Las Vegas, Nevada. The Company lists on the OTC Markets Group’s OTCQB.

GB Sciences’ R&D team is pursuing new formulations derived from specific strains of cannabis, creating patented formulations that will help patients. The Company provides clean, reliable raw materials for numerous cannabis products and research initiatives. It is creating novel formulations and seeking patents for treatments that will directly assist patients.

This past May, GB Sciences announced the initial harvest at its Cultivation Lab facility in Las Vegas. When fully operational, Cultivation Lab will contain 7,200 cannabis plants under 600 grow lights within its 28,000 ft.

The expectation is that Cultivation Lab will produce roughly $10 million in yearly revenue. The main directive of GB Sciences since the Company’s inception has been the creation of a quality controlled cannabis cultivation and extraction facility to provide the compounds for formulating medicines to treat a broad array of diseases.

GB Sciences has added its own medical-grade retail brand to its portfolio. This portfolio includes granted-medical and provisional-recreational use Nevada cultivation licenses and patent-pending medical formulations.

In July, GB Sciences announced it harvested its first crop and sold 63 pounds of premium flower while holding back 66.5 pounds for conversion to medical grade oil. GB Sciences (based on conservative estimates and production volumes) projects revenue of $2.8M through December 31, 2017. It will complete its full Fiscal Year (FY) projections (March 31, 2018) within the next few months.

GB Sciences signed a Consulting Services Agreement with Worldwide Clinical Trials, Inc. This Agreement is to evaluate its Intellectual Property (IP) portfolio and to assist with pre-IND planning for its proprietary cannabis-based formulations. These pre-IND consulting services will be performed by the Chief Medical and Scientific Officer (CMSO) of Worldwide, Mr. Michael F. Murphy, MD, PhD, as the representative of an extended Worldwide team.

Earlier this month, GB Sciences announced an agreement with the Los Coyotes Band of Cahuilla and Cupeno Indians (Los Coyotes) for establishing cannabis operations on the tribe's lands near Warner Springs, California. The nonbinding Joint Statement of Intent outlines plans to construct and operate facilities to grow, manufacture, as well as distribute commercial cannabis and cannabis products in California.

GB Sciences, Inc. (GBLX), closed Wednesday's trading session at $0.3737, down 1.66%, on 264,705 volume with 117 trades. The average volume for the last 60 days is 520,725 and the stock's 52-week low/high is $0.21/$1.56.

Biotricity, Inc. (BTCY)

Stock News Now, InvestorsHub, 4-Traders, Finance Registrar, SmallCap Network, Stockhouse, GuruFocus, Barchart, and News reported previously on Biotricity, Inc. (BTCY), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Biotricity, Inc. is a medical diagnostic and consumer healthcare technology company listed on the OTC Markets Group’s OTCQB.  The Company’s commitment is to deliver biometric remote monitoring solutions. It delivers these solutions to the medical and consumer markets. This includes diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity is based in Redwood City, California.

The Company’s vision is putting health management into the hands of the individual. Biotricity is working to support the self-management of critical and chronic conditions with the use of innovative solutions to ease the growing burden on the healthcare system. Biotricity’s Research and Development (R&D) continues to center on the preventative healthcare market.

Biotricity has created two ECG monitoring devices. The design of these is to improve upon the tools and devices available in the contemporary market.

For Physicians, the Company has its Bioflux. This is a medical technology solution for physicians to test and diagnose patients, and benefit from an inventive system, which provides continuing active monitoring for up to 30 consecutive days.

Bioflux consists of an ECG monitoring device, software, as well as access to a monitoring lab. The Bioflux software component is an acquisition that is already Food and Drug Administration (FDA) cleared. It is a standard for ECG monitoring in hospitals and cardiac clinics.

For Consumers, Biotricity has its Biolife. This is a preventative care solution. It leverages the expertise gained from the Company’s Bioflux.

The design of Biolife is to assist individuals in tracking their progress in real-time so they can stay motivated to make lifestyle changes. Biolife helps users make lifestyle changes through uniting medically relevant ECG data with social media interactivity and a lifestyle log.  

Biotricity has partnered with Global to Local (G2L). This collaboration between Biotricity and G2L will first focus on building distinct solutions for outcome measurements for individuals suffering from chronic disease.

Yesterday, Biotricity announced that it completed the alpha version of Bioflux 2.0’s deep data diagnostic solution in accordance with FDA arrhythmia diagnostic standards. Biotricity’s intention is to take advantage of its new artificial intelligence (AI) and deep data technology in arrhythmia analysis in its Bioflux 2.0 solution and concentrate on improved accuracy, faster diagnostics for patients, more efficient monitoring, and improved call center efficiency.

Biotricity, Inc. (BTCY), closed Wednesday's trading session at $1.90, up 11.76%, on 94,076 volume with 155 trades. The average volume for the last 60 days is 48,085 and the stock's 52-week low/high is $1.68/$19.50.

Where Food Comes From, Inc. (WFCF)

MicroCapClub, The Bowser Report, Marketbeat, Market Exclusive, SmallCapVoice, OTC Markets, and Wyatt Investment Research reported earlier on Where Food Comes From, Inc. (WFCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Where Food Comes From, Inc. is a trusted resource for third party verification of food production practices. The Company supports more than 10,000 farmers, ranchers, processors, retailers, distributors,  and restaurants with a wide variety of value-added services through its IMI Global, International Certification Services, Validus Verification Services, Sterling Solutions, A Bee Organic, and SureHarvest units. Where Food Comes From is based in Castle Rock, Colorado. 

The Company has a solutions portfolio. Its portfolio encompasses beef, pork, poultry, lamb, dairy, eggs, and organic. The Company’s solutions portfolio includes offerings ranging from source and age, non-hormone and humane handling to organic, non-GMO (Genetically Modified Organism) and gluten free.

Where Food Comes From acquired a 60 percent  interest in privately held SureHarvest, Inc.  SureHarvest  is a foremost provider of agri-food sustainability solutions. SureHarvest provides an extensive array of sustainability and farming MIS solutions, certification and compliance management, and a host of professional services.

A Bee Organic is a USDA Accredited Certification Agency. A Bee Organic provides customers with National Organic Program (NOP) certifications for hydroponic, aquaponic, in-ground, and wild crops. This includes avocados, blueberries, citrus and stone fruits, greens, as well as manzanita.

Where Food Comes From’s wholly-owned subsidiary Sterling Solutions is a leading provider of third-party verification services in the western United States. Sterling Solutions serves large dairies, calf ranches, and cattle operations. It  has greater than 10 years of on-farm auditing experience.

Where Food Comes From’s  Validus Verification Services is a leader in independent certification of socially responsible production practices covering pork, poultry, and dairy products.  Validus Verification Services  is a wholly-owned subsidiary of the Company

The Where Food Comes From® retail and restaurant labelling program uses the verification of product attributes to connect consumers to the sources of the food they buy via product labelling and web-based information sharing and education. Employing QR code technology, consumers’ can rapidly access information regarding the producers behind their food.

Where Food Comes From has acquired privately held software maker Sow Organic, Inc., in a transaction valued at $900,000. Where Food Comes From’s SureHarvest subsidiary, which offers its own patented SaaS solution in the sustainability space, will oversee the integration of Sow Organic.

Last week, Where Food Comes From announced that its IMI Global division established an exclusive partnership with International Genetic Solutions (IGS) to offer the IGS Feeder Profit Calculator within its group of verification services for beef producers.

The IGS Feeder Profit Calculator uses the largest and most wide-ranging set of management and genetic data available in the beef industry to calculate the Relative Value of feeder calves in a one-of-a-kind, breed agnostic, independent way. The IGS Feeder Profit Calculator will be offered to all of IMI Global’s customers at no added cost to their existing verification programs.

Where Food Comes From, Inc. (WFCF), closed Wednesday's trading session at $2.02, up 1.00%, on 5,000 volume with 5 trades. The average volume for the last 60 days is 14,885 and the stock's 52-week low/high is $1.76/$3.50.

Zoom Telephonics, Inc. (ZMTP)

FeedBlitz, Marketbeat, Wall Street Mover, OtcWizard, SmallCapVoice, and OTC Picks reported on Zoom Telephonics, Inc. (ZMTP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Zoom Telephonics, Inc. is a top manufacturer of cable modems and other communications products. The Company designs, produces, markets, and supports cable modems and other communications products under the Zoom, Hayes®, and Global Village® brands. Established in 1977,  Zoom Telephonics has its corporate headquarters in Boston, Massachusetts.  

  Zoom’s products include cable modems & gateways, dial-up modems, mobile broadband modems and routers, wireless networking products, ADSL gateways, Bluetooth wireless products, wireless keyboards, and ZoomGuard wireless sensors & controls.

In addition, products include asymmetric digital subscriber line modems, wireless local area networking products, Voice Over IP products  (VoIP), wired networking equipment, dialers and related telephony products, wireless sensors and controls, phone jacks and AC power adapters, and language-related specifics. 

  In May 2015, Zoom Telephonics signed an exclusive license agreement with Motorola Mobility LLC. This license agreement is for the Motorola brand in connection with consumer cable modem products. This includes cable modem bridges, cable modem/routers, and cable set-top boxes containing cable modems, for the U.S. and Canada. This agreement started on January 1, 2016 and runs through December 31, 2020.  

  In September 2017, Zoom Telephonics announced the signing of an amendment to its license agreement with Motorola Mobility to include the exclusive worldwide rights for the Motorola brand for consumer-grade cellular modems and gateways, DSL modems and gateways, and MoCA (Multimedia over Coax) adapters.

Moreover, the amendment grants Zoom Telephonics non-exclusive worldwide rights to use the Motorola brand for consumer-grade cellular home sensors. These are products designed, marketed, and sold for use by consumers for their personal, family, or household use.

Last month, Zoom Telephonics announced that it started volume shipments of two Motorola modem plus router combinations. One is the Motorola MD 1600 DSL Modem plus AC1600 WiFi Gigabit Router. The other is the Motorola MG7700 24X8 Cable Modem plus AC1900 Dual Band Wi-Fi Gigabit Router with Power Boost.

The MD1600 is a high-speed DSL modem with Motorola extras such as user-friendly setup, and advanced surge and lightning protection. Model MD1600 provides first-rate WiFi coverage.

The Motorola MG7700 cable gateway includes a built-in AC1900 3x3 wireless gigabit router. The MG7700 provides the range, wireless speeds, and networking support required for multimedia, Internet video, and high-performance networking in an office or home.

Zoom Telephonics, Inc. (ZMTP), closed Wednesday's trading session at $2.80, even for the day, on 375 volume with 1 trade. The average volume for the last 60 days is 8,203 and the stock's 52-week low/high is $1.71/$4.11.

Weyland Tech, Inc. (WEYL)

DreamTeamNetwork, Wall Street Mover, and OTCJournal reported earlier on Weyland Tech, Inc. (WEYL), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Weyland Tech, Inc. is a provider of mobile business applications. The focus of the Company’s CreateApp platform is on the Asia markets. Weyland Tech presently offers the CreateApp platform directly in Singapore, India (Jaipur), and the U.S.A. and Canada. The Company’s CreateApp platform is provided in 12 languages. The "CreateApp" platform enables SMBs (Small-Medium-Sized Businesses) to create a mobile application without the requirement of technical knowledge and background. Weyland Tech is headquartered in Hong Kong.

Weyland Tech currently offers a DIY (Do-it-Yourself) App builder through a 'white label' platform. It offers this through strategic partnerships in the EU (minus Russia, Turkey, Armenia, Azerbaijan); Malaysia; Hong Kong/South China; Indonesia; and North/Central/South America. It will offer this in Korea through IAM, Inc.

Weyland Tech signed a Master Service Agreement (MSA) with Orient Asia Pacific Limited (OAP). This is for the Indonesia market. OAP is a software and digital technology consulting enterprise. In September 2016, Weyland Tech announced that it signed a strategic licensing agreement with BGT Corporation Public Company Limited (BGT), for the Thailand market.

Weyland Tech's partner in Indonesia, OAP, recently signed an agreement to provide a stored-value 'top-up' application targeted at the 120 million adults living without access to traditional banking facilities. The design of the application is to be offered through major telecommunications providers in Indonesia. OAP has started a pilot program to 20 communities in Indonesia. OAP will offer the community application to the other 500,000 communities across Indonesia upon success of the pilot.

Weyland Tech has entered into an advisory agreement with TMC Prime Pte. Ltd (TMC). This agreement is to secure strategic investments by Southeast Asian technology companies and high-net-worth individuals with experience investing in technology firms. TMC will commit to fund up to $10 million USD over a period of one year by way of direct investments into Weyland Tech. The intention of these funds is to be used for expansion and pilot programs aimed at exploiting the enormous potential in the fast expanding Indonesian mobile commerce (m-commerce) market.

Regarding strategic partnerships, Weyland Tech has partnered with and is finalizing partnerships with major payment gateways in the ASEAN region and the incumbent telecoms that provide payment solutions to the different locales in nations like Indonesia. Weyland Tech has a strategic partnership with DPEX. This is one of the ASEAN regions incumbent logistics players with infrastructure throughout every country in the region. This enables Weyland Tech to provide delivery for e/m-commerce customers.

Weyland Tech’s exclusive Eurozone partner, Augicom S.A., has entered into a partnership with Orange Pro. As part of the agreement, Weyland Tech's CreateApp will be made available to Orange Pro clients through the "la Carte Pro" program or 'Pro Card' in English. The "Pro Card" program of Orange is a loyalty program for independent professionals and SMBs. Augicom is an active provider of voice/data telecommunication minutes. It has major partnerships with major European carriers.

Weyland Tech, Inc. (WEYL), closed Wednesday's trading session at $1.88, up 56.67%, on 128,414 volume with 203 trades. The average volume for the last 60 days is 42,655 and the stock's 52-week low/high is $0.962/$7.08.

PetroShare Corp. (PRHR)

DreamTeamNetwork, SmallCapVoice, Stockhouse, InvestorsHub, and CapitalCube reported earlier on PetroShare Corp. (PRHR), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

PetroShare Corp. is a domestic oil and natural gas exploration and development company. It targets capital deployment opportunities in established unconventional resource plays. The Company formed to investigate, acquire, and develop oil and gas properties in the Rocky Mountain and mid-continent regions of the United States.  PetroShare is headquartered in Englewood, Colorado and the Company lists on the OTC Markets Group’s OTCQB.

PetroShare’s properties include Todd Creek Farms (Southern Wattenberg Field, NE Colorado; Niobrara and Codell Oil and Gas Development). The Company’s present focus is in the Niobrara/Codell formations and adjacent oil and gas producing zones in the Rocky Mountain region. Specific targets are in the Wattenberg field within the DJ Basin of northeast Colorado.

PetroShare is expanding its group of properties through organic drilling and development, in addition to strategic acquisitions and joint ventures (JVs). It acquired an initial acreage position of roughly 1,280 gross acres (333 net acres) in the core of the oil dominated Niobrara/Codell resource development fairway in the southern end of the Greater Wattenberg Field area of NE Colorado.

The Company’s properties additionally include the Buck Peak Prospect (Sand Wash Basin, NW Colorado; Niobrara Oil Development).  This Prospect is 7,700 gross acres (1,000 net acres) located in Moffat County. PetroShare has drilled and completed two producing wells in this prospect.

The Buck Peak Prospect targets oil and associated wet gas from the fractured Niobrara Shale formation. The Company’s Shook pad development program comprises 6 Codell wells and 8 Niobrara wells targeting all three Niobrara benches. 

PetroShare has secured the rights-of-way required to start pipeline construction and hook up on its Shook pad. It has also assembled six additional drill site spacing units (DSUs) with surface use agreements across its South Brighton assets and has approximately 100 permits approved, submitted or in process for operated horizontal wells in the region.

Recently, PetroShare provided an update on its operated and non-operated activities in the Wattenberg Field in the Denver Julesberg Basin in Colorado.

Mr. Frederick J. Witsell, PetroShare President, said, "Our participation in non-operated wells this year is contributing to production growth and we estimate that we will average between 900-1,200 BOED during the second quarter, which is up from the 680 BOED rate in the first quarter of 2018. We are currently completing the last of 14 wells on our operated Shook pad.”

PetroShare Corp. (PRHR), closed Wednesday's trading session at $1.30, even for the day, on 265 volume with 2 trades. The average volume for the last 60 days is 3,033 and the stock's 52-week low/high is $0.75/$1.85.

SCI Engineered Materials, Inc. (SCIA)

Zacks, OTC Markets, Stockhouse, and InvestorsHub reported on SCI Engineered Materials, Inc. (SCIA), and today we report on the Company, here at the QualityStocks Daily Newsletter.

SCI Engineered Materials, Inc. is a global supplier and manufacturer of advanced materials for physical vapor deposition (PVD) thin film applications. This includes thin film solar products. The Company works closely with end users and original equipment manufacturers (OEMs) to develop unique, customized solutions. It provides targeted solutions for thin film applications.

SCI Engineered Materials is based in Columbus, Ohio. The Company’s shares trade on the OTC Markets’ OTCQB.

Major markets that SCI Engineered Materials serves include architectural glass, optic & photonic, solar photovoltaic, transparent electronics, and solid-state lithium thin film battery. The Company provides precision machining of backing plates & tubes to customer or OEM specifications. 

SCI provides ceramic and metal targets for use in sputtering and laser ablation systems. Furthermore, it manufactures high performance metal, ceramic, and alloy bulk-form evaporation sources in almost any customer defined configuration.

SCI Engineered Materials is an ISO 9001-2015 Registered Provider of PVD Materials. The Company is a recognized leader in the development of “Transparent Conductive Oxide (TCO)” materials for varied industries.

In addition, SCI processes a wide assortment of custom ceramic powders in house. The Company offers a broad variety of single crystal substrates for making first-rate thin films. Services that SCI provides include advanced ceramic powers, vacuum hot pressing, machining, bonding, as well as quality assurance. 

SCI Engineered Materials earlier announced that it was notified by the U. S. Patent and Trademark Office (USPTO) that it will be granted a patent titled “Display having a transparent conductive oxide layer comprising metal doped zinc oxide applied by sputtering” (US 2016/0041418 A1). The patent is directed broadly to devices and methods involving numerous end-use applications. These include display, smart windows, and other electroluminescent devices.

In June, SCI Engineered Materials announced that it received a $2 million order for transparent conductive oxide products from a Cadmium Indium Gallium Selenide (CIGS) thin film solar cell manufacturer. The expectation is that first shipments will commence later this year and be completed during 2019.

Mr.  Dan Rooney, SCI Engineered Materials’ President and Chief Executive Officer, stated, “We are excited to receive this significant order, the largest one in our 31-year history, from a new customer in China... Based on orders received year-to-date, our sales of thin film solar products will be significantly greater than 2017.”

SCI Engineered Materials, Inc. (SCIA), closed Wednesday's trading session at $1.42, up 1.43%, on 1,001 volume with 2 trades. The average volume for the last 60 days is 4,951 and the stock's 52-week low/high is $0.62/$1.60.

Tapinator, Inc. (TAPM)

Pennybuster, TopPennyStockMovers, Marketbeat, and TheMicrocapNews reported earlier on Tapinator, Inc. (TAPM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Tapinator, Inc. is a developer and publisher of mobile games and decentralized applications on the iOS, Google Play, Amazon and Ethereum platforms. The Company generates revenues via the sale of branded advertisements, paid downloadable games, and premium in-game content. Mr. Ilya Nikolayev is the Company’s Chief Executive Officer (CEO). Mr. Nikolayev is an accomplished technology executive. He previously served as the CEO and Co-Founder of Familybuilder.

An emerging mobile gaming leader, Tapinator is based in New York, New York. The Company has product development teams in the U.S., Canada, Germany, Pakistan, Indonesia, and Russia. Established in 2013, Tapinator lists on the OTC Markets Group’s OTCQB.

The Company's portfolio comprises greater than 300 mobile gaming titles, which collectively have achieved over 400 million player downloads. This includes games such as ROCKY™, Combo Quest, Video Poker Classic, Solitaire Dash, and Burn It Down. Tapinator has shifted its emphasis from Rapid-Launch Games to the more lucrative Full-featured Games opportunity.

Tapinator has formed a new subsidiary, Revolution Blockchain, LLC, to develop and publish distributed apps and games that leverage blockchain technology. Revolution Blockchain's first product will leverage blockchain technology for payment (the purchase and sale of virtual assets) and the storage of these assets through non-fungible tokens that live on the blockchain.

At the end of May, Tapinator announced that it released the Early Access version of BitPainting. This is a crypto-collectibles platform for the international art market.

Ilya Nikolayev, Tapinator Chief Executive Officer, said, "After significant development efforts by our team, we are very excited to announce the initial launch of BitPainting, a new digital platform for collecting iconic art on the blockchain. BitPainting allows art enthusiasts to collect and interact with rare virtual artwork on the Ethereum network. Art lovers can acquire iconic works, mint editions, sell, gift and explore famous works from world-renowned artists.”

Tapinator, Inc. (TAPM), closed Wednesday's trading session at $0.075, even for the day, on 688,582 volume with 19 trades. The average volume for the last 60 days is 260,763 and the stock's 52-week low/high is $0.0644/$0.72.

Mountain High Acquisitions Corp. (MYHI)

Wealth Insider Alert, Market Intelligence Center, StreetAuthority Daily, Stockgoodies, Laissez Faire Today, Cannabis Financial Network, TopPennyStockMovers, SmallCapVoice, Integrity Solution IR, Charms Investments LTD,, Wallstreet Profiler, and PennyDoctor reported earlier on Mountain High Acquisitions Corp. (MYHI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Mountain High Acquisitions Corp. is a turnkey, pioneering infrastructure provider to licensed cannabis growers, processors, as well as producers in regulated markets. The Company assists in the design, permitting, development, and operation of scalable infrastructure. Mountain High Acquisitions has its headquarters in Scottsdale, Arizona. The Company’s shares trade on the OTC Markets Group’s OTCQB. 

Mountain High Acquisitions also helps licensed operators take advantage of scientific and technological innovations specifically geared to optimize the cultivation and processing of cannabis. 

In May of this year, Mountain High Acquisitions announced that it entered into an agreement with D9 Manufacturing, Inc. The Company has engaged D9 to help in the identification, acquisition, and development of infrastructure and technology opportunities in the expanding cannabis market. D9 Manufacturing is an Arizona-based company. It provides a broad array of engineering, manufacturing, and consulting services to the cannabis sector. 

Mr. Alan Smith, Mountain High Acquisitions’ Chief Executive Officer, said, "To date we have primarily focused on businesses within the hemp and CBD nutraceutical space. However, this agreement with D9 will allow us to take advantage of opportunities in the broader cannabis space. We see tremendous potential for growth as we expand to serve as a turnkey, cutting-edge infrastructure provider to licensed cannabis growers, processors and producers in regulated markets." 

Recently, Mountain High Acquisitions announced that, together with D9 Manufacturing, it is launching a pilot project targeted at proving a turnkey infrastructure model the Company intends to roll out in highly promising cannabis markets, including California, Washington, and Arizona. The aim is to help licensed cannabis growers overcome the key business challenge of financing steep start-up infrastructure costs. 

To start this project, Mountain High Acquisitions acquired two state-of-the-art intermodal containers engineered and designed specifically for growing cannabis. The opportunity to acquire the grow containers was presented to the Company by D9 Manufacturing. As a part of this initial pilot, Mountain High Acquisitions will lease its first two containers to D9 Manufacturing for use in licensed grow operations in Arizona and California.   

Mountain High Acquisitions Corp. (MYHI), closed Wednesday's trading session at $0.062, up 3.33%, on 328,974 volume with 41 trades. The average volume for the last 60 days is 759,988 and the stock's 52-week low/high is $0.0385/$0.45.

Newgioco Group, Inc. (NWGI)

OTC Markets, TradingView, MarketWatch, and reported on Newgioco Group, Inc. (NWGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Newgioco Group, Inc. is a betting software technology company. It provides regulated leisure lottery and gaming products and services via licensed subsidiaries based in Europe. The Company, together with its wholly-owned subsidiaries, is a fully-licensed and integrated gaming software technology enterprise.

Newgioco Group has its corporate office in Toronto, Ontario, as well as an office in Rome, Italy. The Company’s shares trade on the OTC Markets’ OTCQB. Newgioco has acquired Multigioco Srl, which is a licensed gaming operator headquartered in Rome.

Newgioco Group plans to aggressively go after attractively priced, fragmented, and profitable gaming operators in Italy. Its aim is to become a top tier gaming operator over a five-year investment time horizon.

Newgioco Group provides its clients a complete set of leisure gaming products and services. These include sports betting, virtual sports, online casino, poker, bingo, lottery, interactive games and slots, and a unique betting platform ( providing Business-to-Business (B2B) and Business-to-Consumer (B2C) bet processing.

Newgioco Group conducts its business chiefly through retail neighborhood betting shops and an internet-based gambling and sports betting software platform under the registered brand Newgioco, by way of its licensed website located in Italy.

In July, Newgioco Group announced that it obtained certification on its betting software platform required by the Italian gaming authority, the Agency of Customs and Monopolies (ADM). By attaining this globally recognized ADM Certification, Newgioco stated that it has demonstrated its dedication to the highest level of security standards and continuous improvement in betting software development, implementation, and oversight.

In early August, Newgioco Group announced the successful launch of its new Betting Platform Technology colloquially called "ELYS." The ELYS software platform went live on August 1, 2017. Therefore, sports betting operations are now processed in-house via ELYS, while skill games, lottery, casino, poker, and other entertainment products will continue through the Company’s strong relationship with Microgame SpA.

In addition, this month, Newgioco Group announced that it filed its 2017 Q2 results with the U.S. Securities and Exchange Commission (SEC). It reported Income Before Interest and Income Tax of $326,616. This represents a profit of $0.01 per share for Q2 of 2017. Non-GAAP Gaming Turnover saw a noticeable improvement, surpassing $102 million for the six months ended June 30, 2017, versus $54.9 million in the prior year.

GAAP Revenue was $7.97 million for the six months ended June 30, 2017, versus $3.27 million for the same period in 2016. This represents an increase of 143.5 percent. The Company’s Total Assets more than doubled from about $3.4 million to $7.25 million, and Cash reserves increased from $121,130 to $2.125 million.

Newgioco Group, Inc. (NWGI), closed Wednesday's trading session at $0.52, even for the day, on 6,100 volume with 3 trades. The average volume for the last 60 days is 94,462 and the stock's 52-week low/high is $0.085/$1.78.

Arch Biopartners, Inc. (ACHFF)

Stockwolf, Wall Street Alerts, Stockwatch, Business Insider, Investors Hangout, OTC Markets, Barchart, Wallet Investor, Marketwired, TradingView, InvestorPoint, Infront Analytics, 4-Traders, Stockhouse, and MarketWatch reported on Arch Biopartners, Inc. (ACHFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Arch Biopartners, Inc. is a portfolio-based biotechnology company listed on the OTCQB. It concentrates on the development of unique technologies, which have the potential to make a major medical or commercial impact. Arch Biopartners has its corporate office in Toronto, Ontario. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Arch Biopartners has established a varied portfolio that includes Metablok (LSALT peptide). This is a potential treatment for inflammation, sepsis and cancer metastasis. The Company’s portfolio also includes AB569. This is a potential new treatment for antibiotic resistant bacterial infections in the lung, urinary tract or wounds.

Furthermore, its portfolio includes ‘Borg’ peptide coatings. These coatings increase corrosion resistance and decrease bacterial biofilm on different medical grade metals and plastics. Arch’s two lead commercial technologies (MetaMx and ABP569) are on track to enter human clinical trials this year. MetaMx™ consists of novel, synthetic peptides that target and attach to BTICs and invasive glioma cells, for the purpose of imaging, diagnosis, and developing targeted therapies to improve patient outcomes and survival rates among glioblastoma patients.

Metablok (renamed “LSALT peptide” in Arch Biopartners communications with the Food and Drug Administration [FDA]) is a novel peptide drug candidate in the Arch development pipeline. It is a potential treatment for inflammation, sepsis and cancer metastasis.

Recently, Arch Biopartners announced it engaged Nucro-Technics (Scarborough, Ontario) to complete the preclinical toxicology and pharmacology studies to support an Investigational New Drug (IND) application for Metablok. This is Arch’s drug candidate for preventing acute kidney injury during cardiac surgery.

Nucro-Technics will be performing the good laboratory practice (GLP) toxicology and pharmacology studies earlier confirmed by the U.S. Food and Drug Administration (FDA) during the pre-IND meeting with Arch Biopartners on April 18, 2018.

Last month, Arch Biopartners announced that it will seek regulatory guidance from the FDA in a pre-Investigational New Drug application meeting (pre-IND meeting) for AB569. This is Arch’s drug candidate for treating antibiotic resistant bacterial infections in the lungs, wounds and urinary tract.

The Company started sponsoring an investigator-initiated Phase I study testing the safety of inhaled AB569 at the Cincinnati Veterans Affairs Medical Center (CVAMC) earlier in 2018. The investigator-initiated Phase I safety trial will be on hold. It will resume again after the IND application is opened and the FDA approves the Phase I study.

In late June, Arch Biopartners announced that it received net proceeds of $332,750 during the current quarter from the exercise of 665,500 warrants with an exercise price of $0.50 per common share. The proceeds will be used for general operations and also the continuing preparation of a pre-Investigational New Drug application for Metablok.

Arch Biopartners, Inc. (ACHFF), closed Wednesday's trading session at $1.2225, up 1.03%, on 5,747 volume with 5 trades. The average volume for the last 60 days is 5,005 and the stock's 52-week low/high is $0.313/$1.2512.

The QualityStocks Company Corner

Pacific Software, Inc. (OTC: PFSF)

The QualityStocks Daily Newsletter would like to spotlight Pacific Software, Inc. (PFSF).

Pacific Software Inc. (OTC: PFSF) is focused on the design, development, and distribution of Hyperledger blockchain technology solutions for application to the specific needs of agriculture, cannabis, and the opioid epidemic.

Pacific Software, Inc. (OTC: PFSF) is focused on the design, development, and distribution of Hyperledger blockchain technology solutions for application to the specific needs of agriculture, cannabis, and the opioid epidemic.

The basic requirements of the systems to be developed include high-throughput transaction processing, traceability or tracking, visibility or monitoring, and transparency throughout the supply and value chains for the stakeholders. The development of this architecture will serve as an online commercial portal to service Pacific Software’s B2B accounts in the sectors below.

For application of its Agri-blockchain based system, Pacific Software will target farm-to-consumer exports to increase transparency, combat theft and counterfeit products, and reduce the health risks associated with shipping “tainted” agricultural products to other countries.

Perceiving blockchain as an ideal mechanism for the complexities of the cannabis industry, Pacific Software will strive to improve the transparency, compliance, and efficiency of the “seed-to-sale” supply chain in states where the plant is legal.

Controlled Substances
With the misuse of opioids on the rise worldwide, Pacific Software aims to apply its blockchain-based system to track opioids from pharmaceutical production to consumers and attempt to identify “Bad Actors” in the supply chain and fight against the global epidemic.

Business Model
The portal will be structured in a B2B format where clients will pay the company transaction fees, royalties, cash, cash equivalents and other forms of compensation to utilize its Hyperledger blockchain applications for their business models.

As the company executes these strategies, each Hyperledger blockchain-based system designed may be organized separately in wholly owned subsidiaries. To enhance its portfolio of holdings, Pacific Software may consider investments in companies where selected markets have imminent profitable results, providing appreciable value for investors and shareholders.

Pacific Software, Inc. (PFSF), closed the day's trading session at $4.00, even for the day. The average volume for the last 60 days is 49 and the stock's 52-week low/high is $4.00/$4.00.

Recent News


The QualityStocks Daily Newsletter would like to spotlight GreenBox POS, LLC (GRBX).

GreenBox POS (OTCQB: GRBX), an innovative hardware and software technology company, was recently the subject of an editorial titled “Meet GreenBox POS – A Blockchain Technology Company That Builds Customized Payment Solutions” by Tech Company News. To view the full article, visit: Also today, CryptoCurrencyWire released a report on the company detailing how GRBX’s latest payment system, QuickCard, has been showing impressive market performance metrics (

GreenBox POS, LLC (OTCQB: GRBX) is a hardware and software technology company that builds customized payment solutions in different industries. The company is headquartered in San Diego, California, with offices in Seattle, Wash.; Las Vegas, Nevada; and Vancouver, British Columbia, Canada. GreenBox, which has been awarded five provisional patents for its blockchain-based technology, delivers a fully integrated, intuitive, easy-to-use, point of sale (POS) system for a variety of businesses across a multitude of different market sectors.

GreenBox develops all software in-house and with international subsidiaries, which allows the company to provide individualized electronics modifications in partnership with different vendors. Custom POS machines are available as an upgrade from existing solutions currently in use. First-time merchants can also take advantage of custom-built kiosk machines powered by blockchain technology, complete with e-wallet integration downloadable via Android or iOS apps, or via installed cash-loading kiosks.

GreenBox develops POS (point of sale) software and hardware solutions; DEL (delivery app, APIs to POS and PAY); PAY (payment app, providing financial APIs to all other components); and KIOSK (deposit, cash and E-wallet management). The following flagship products, services and custom hardware are currently available:

  • QuickCard – the QuickCard kiosk handles all cash issues, both for cashless operations and for legacy cash; performs direct and immediate deposits from cash to blockchain and confirms bank account availability within minutes. Accepts cash, debit/credit cards, or ACH directly to most banks while settling funds instantly. All records are stored securely on blockchain. No faster deposit solution is available in the regular and non-traditional banking systems (unless depositing cash directly into a cash machine connected to a bank branch).
  • POS Solutions – GreenBox software, developed in-house and with international subsidiaries, features operational compliance, financial audit prep, expense tracking, tax payments, register-specific features, and data fidelity controls (backup/restore, cloud security, privacy, etc.). GreenBox POS software is fully integrated with Del and Pay Systems and features front register mode and back-end admin mode, in addition to in-admin mode to manage employees, vendors, expenses, taxes and compliance. All records are stored on blockchain with data reliably secured and protected.
  • LOOPZ – This delivery software solution offers service dispatcher back-end technology with manual and automatic modes. The software is uniquely designed to be effectively utilized for mobile delivery service operations with full autonomous dispatch capabilities. LOOPZ provides the following features: two mobile apps (driver and consumer) running on Android and IOS; direct reporting to point of sale inventory and use of pay for instant settlements; separate escrow setup for tips and merchant sale; all data and information is securely hosted on a blockchain platform.

The management team at GreenBox includes CEO Fredi Nisan, who comes from the POS and merchant services business sector. He recently completed a successful exit in the POS and ERP business, which he founded and managed through the exit. Joining Nisan is Ben Errez, executive vice president, who comes from the investment, consulting and big software and hardware industries. His previous executive roles include positions at Microsoft (including engineering management of Microsoft Office for complex scripts); IBM (with which he had an exit); and Intel. Errez has also consulted the world’s biggest private economy, World Trade Center, on payment systems, security, reliability and privacy of software and hardware development.

GreenBox POS, LLC (GRBX), closed the day's trading session at $0.64505, off by 0.76%, on 20,717 volume with 25 trades. The average volume for the last 60 days is 24,531 and the stock's 52-week low/high is $0.017/$0.99.

Recent News

First Cobalt Corp. (TSX-V: FCC) (OTCQX: FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF).

First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) was mentioned today in an article on OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, which today announced the second quarter 2018 performance and quarterly rebalancing of the OTCQX® and OTCQB® indexes, including the OTCQX Canada Index and the OTCQX Dividend Index.

First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance.

First Cobalt Corp. (FTSSF), closed the day's trading session at $0.2745, up 0.99%, on 126,035 volume with 59 trades. The average volume for the last 60 days is 215,738 and the stock's 52-week low/high is $0.242/$1.3041.

Recent News

Earth Science Tech, Inc. (OTC: ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech (OTC: ETST) recently selected ‘Hygee’ as the name for its MSN-2 home testing medical kit for women. To view the full article, visit:

Earth Science Tech, Inc. (OTC: ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.77, up 1.32%, on 3,175 volume with 11 trades. The average volume for the last 60 days is 11,505 and the stock's 52-week low/high is $0.324/$1.62.

Recent News

SinglePoint, Inc. (OTCQB: SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint Inc. (OTCQB:SING) provides video of corporate presentation shared at the 2018 National Investment Banking Associations New York conference. SinglePoint NIBA Presentation VIDEO

SinglePoint, Inc. (OTCQB: SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.04, up 6.38%, on 2,148,144 volume with 163 trades. The average volume for the last 60 days is 7,216,257 and the stock's 52-week low/high is $0.0176/$0.415.

Recent News

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (TSX: TGOD).

CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering The Green Organic Dutchman Ltd.'s (TSX:TGOD) (OTCQX:TGODF) recently proposed spin off of a company focused on investments and acquisitions.

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at

The Green Organic Dutchman (TSX: TGOD), closed the day's trading session at $5.70, up 0.18%, on 201,450 volume. The stock's 52-week low/high is $3.50/$8.28.

Recent News

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF).

PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced the launch of a medicinal cannabis division, advancing PreveCeutical’s vision of becoming a global preventive healthcare company. To view the full press release, visit:

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word “PreveCeutical” – a combination of the words “preventive” and “pharmaceutical” – was a precursor to the company’s formation and incorporation in October 2015.

The company’s first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical’s research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical’s gene-silencing technology would effectively “turn off” the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical’s science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland’s (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.’s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company’s core.

PreveCeutical Medical Inc. (PRVCF), closed the day's trading session at $0.032, up 6.67%, on 554,940 volume with 65 trades. The average volume for the last 60 days is 525,518 and the stock's 52-week low/high is $0.002/$0.20.

Recent News

Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8)

The QualityStocks Daily Newsletter would like to spotlight Victory Square Technologies Inc. (VSQTF).

Victory Square Technologies (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8), a venture builder that creates, funds and empowers entrepreneurs, this morning announced that it will acquire 15% percent of all issued and outstanding shares of Cloud Benefit Solutions Inc. (“Cloud Advisors”) for $300,000 CAD in total consideration, subject to all requisite regulatory approvals. To view the full press release, visit:

Victory Square Technologies Inc. (VSQTF) is a venture builder that creates, funds and empowers entrepreneurs working in the fields of blockchain technology, virtual reality, artificial intelligence, personalized health, gaming and film. As a technology incubator, Victory Square invests in game-changing entrepreneurs who are provided access to education programs, global mentorship networks, distribution partners, creative workspaces, resources, and other forms of operational support to help them scale internationally.

Victory Square has made multiple early partnerships and investments in the blockchain space. Approximately three years ago the company incubated and invested in BTL Group, which is now a $150 million dollar TSX-listed company offering blockchain solutions across multiple industries with particular focus on the finance, energy and gaming sectors. BTL’s showcase product – Interbit – is a blockchain platform that facilitates the rapid development of business applications that dramatically improve efficiency. Some of the world’s largest institutions are using Interbit to explore new opportunities on private blockchains.

A new social sports betting platform to be developed by Victory Square’s wholly owned subsidiary, FansUnite Media Inc. As a social sports data platform, FansUnite relies on robust data to allow members of its community to engage with like-minded individuals by collaborating, discussing, and predicting the winners of sporting events with a free virtual currency. The integration of blockchain technology into FansUnite’s social sports data platform could also lead to blockchain initiatives developed by other divisions and subsidiaries of Victory Square.

Integral to the FansUnite platform is the introduction of FAN Tokens, an in-game currency purchased with the cryptocurrency Ethereum that token holders can use to place wagers. FansUnite members will be able to earn FAN Tokens through participation in any number of networking effects identified in the company’s Bounty program.

“Blockchain technology and the inherent security it provides will enable us to push every envelope we can to build the most dynamic and responsive social sports betting platform,” said Darius Eghdami, Co-Founder and Chief Executive Officer of FansUnite. “The opportunity to secure data through Blockchain certainly appeals to the accountant in me and we are confident it will become the gold standard among sports betting sites around the world.”

Company subsidiary Victory Square Health Inc., which serves as the venture arm dedicated to companies focused on the development of solutions in personalized health technologies, has also invested in Personalized Biomarkers Inc. (PBI). PBI develops test kits that reliably predict the expected response to a number of therapies prior to prescription, with an initial focus on diabetes. Within this field, five potential biomarkers have been identified, allowing PBI to enter a $4 billion market opportunity.

“We are excited for the opportunity to partner with Personalized Biomarkers as they have correctly identified a massive market opportunity, and have formed an exceptional team of industry leaders,” said Shafin Diamond Tejani, Chief Executive Officer of Victory Square. “This is another investment that is fully aligned with our newly created subsidiary, and one we expect to significantly impact the landscape of personalized medicine.”

A partnership with Insight Diagnostics Inc., also through Victory Square Health, will focus on the development of a personalized diagnostic solution for the improved management and prevention of Type II diabetes.

The company’s investment in V2 Games, a development and publishing studio of high-quality mobile games, is another example of incubating great ideas. V2 Games is well known for its successful launch of PAC-MAN Bounce and Beast Brawlers, two of the company’s releases that are capturing the gaming world by the millions of downloads.

In a move designed to strengthen its presence in film and entertainment, Victory Square has acquired a 40 percent equity stake in United Film Fund II, LLC, which is producing three major motion pictures in 2017 and 2018 including “What They Had,” starring two-time Academy Award winner Hilary Swank.

“This kind of investment in entertainment and film represents a major plank for our Company going forward and we consider ourselves fortunate to have the opportunity to acquire this 40% stake in the Film Fund,” said Tejani, who has launched more than 40 startups in 21 countries that employ hundreds of people and generate more than $100 million in annual revenues. “We believe it’s another strong initiative in film production for us and our stakeholders,” he added.

Victory Square has strategically positioned itself in the legal cannabis industry through an investment in Tantalus Labs, a Canadian-based cannabis cultivation company. Tantalus Labs optimizes plant health and sustainable cultivation by using a unique, environmentally controlled greenhouse engineered specifically for growing cannabis. Called a “SunLab,” the greenhouse takes 90 percent less electricity, uses filtered rainwater, and cools the growing environment to prevent stagnant moisture, recycling the air every 7 minutes to achieve maximum airflow.

Victory Square and its leadership team have seamlessly transitioned from its former identity as Fantasy 6 Sports Inc, a company focused solely on fantasy sports, mobile gaming and immersive sports, to a strategic technology company that creates, funds and successfully executes leading-edge ideas. A long-time technology entrepreneur and advocate of the industry, Tejani received the Person-of-the-Year Award at the 2017 Technology Impact Awards in British Columbia, a hallmark award category that recognizes betterment of the tech industry through leadership and philanthropic or enterprise skills and talents. Tejani has pledged to match up to $1 million in donated funds to be shared by a number of Canadian endeavors aimed at education and child-safe projects.

“These are exciting and important steps in the evolution and growth of our Company, and which properly and fully align with our strategic plan focusing on our core competencies in Blockchain Technology, Artificial Intelligence, Gaming, Personalized Health, Film and Virtual, Augmented and Mixed Reality,” said Tejani. “We’re spurred on by the success we have had in building on our original forays into fantasy sports, mobile gaming and immersive sports. In addition, we are energized by our most recent initiatives in sports, personalized health and entertainment and the confidence being shown by our shareholders in the dynamic direction of the Company.”

Victory Square Technologies and its management team believe innovation, incubation of excellent ideas and social responsibility are at the core of its growing success.

Victory Square Technologies Inc. (VSQTF), closed the day's trading session at $0.6352, off by 0.75%, on 7,760 volume with 5,161 trades. The average volume for the last 60 days is 25,900 and the stock's 52-week low/high is $0.298/$3.32.

Recent News

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

The growth of advanced automotive technology has led to the rise of companies such as Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), an innovator in advanced vision sensor systems for assistant driving, semi and fully autonomous vehicles.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed the day's trading session at $3.04, off by 1.62%, on 14,489 volume with 54 trades. The average volume for the last 60 days is 58,507 and the stock's 52-week low/high is $2.44/$8.42.

Recent News

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Cannabinoids are poorly absorbed by the body’s gastrointestinal tract, a trait that Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) lipophilic enhancement technology DehydraTECH™ is changing. Previously, consumers have turned to cannabis smoking to achieve higher effectiveness.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.60, off by 3.03%, on 183,895 volume with 339 trades. The average volume for the last 60 days is 241,813 and the stock's 52-week low/high is $0.3202/$2.54.

Recent News

DPW Holdings, Inc. (NYSE American: DPW)

The QualityStocks Daily Newsletter would like to spotlight DPW Holdings, Inc. (DPW).

Diversified holding company DPW Holdings, Inc. (NYSE American: DPW) this morning announced that Microphase Corporation, a majority-owned subsidiary of Coolisys Technologies, Inc., a part of DPW Holdings’ diversified portfolio, secured a $2.1 million contract award from a first-tier U.S. government defense contractor to supply its sophisticated communications filters to be used in combat warfare system components. To view the full press release, visit:

DPW Holdings, Inc. (NYSE American: DPW), is a diverse holding company pursuing a growth strategy of  acquiring undervalued assets with disruptive technologies with a global impact.

The company invests in diverse industries within the commercial, defense/aerospace, industrial, communication, medical, crypto-mining, hospitality, textile, and corporate investment/lending sectors. DPW has evolved and grown from being a leader in advanced power products. Through its subsidiaries, the company continues to be a leader and supplier of innovative technologies, advanced design and development services, and state-of-the-art power products and solutions.

Through its wholly owned Coolisys Technologies, Inc. subsidiary, DPW is committed to offering world-class technology-based solutions for critical applications and lifesaving services that are primarily driven by innovation. Coolisys targets to the defense, aerospace, naval, homeland security, medical, telecom, datacom and industrial markets. Its growth strategy centers on core markets that are characterized by “high barriers to entry” and require specialized products and services not likely to be commoditized. Through a portfolio of companies, Coolisys is engaged in developing and manufacturing advanced switching power products and power solutions that utilize a customized digital power management and resonant topology to attain:

  • The highest efficiency and highest density power converters and inverters
  • Specialized complex airborne high-frequency, radio frequency (RF), and microwave detector-log video amplifiers (DLVA)
  • Very high-frequency filters
  • Naval power conversion and distribution equipment

Coolisys offers its technology and services through three primary groups: the Power Solutions Group (PSG), the Defense and Aerospace Solutions Group (DSG), and the Advanced Service Industries (ASI) Group. Coolisys manages five divisions:

  • Digital Power Corporation, a leader in providing power electronics technology that is based in northern California.
  • Digital Power Limited dba Gresham Power Ltd, a designer and manufacturer of power distribution systems primarily for Naval use that is based in Salisbury, UK.
  • Microphase Corporation, a designer and manufacturer of microwave electronics technology that is based in Shelton, Connecticut.
  • Power-Plus Technical Distributors, a value-added distributor that is based in Sonora, California.
  • Enertec Systems, a developer and manufacturer of specialized advanced electronic systems for the defense and aerospace sectors that is based in Karmiel, Israel.

DPW’s portfolio of wholly owned subsidiaries also includes Digital Power Lending, LLC (DPL), a California private lending company operating under Financial Lender’s License ##60DBO-77905. DPL is dedicated to strategically providing capital to small and middle-size businesses for an equity interest in addition to loan fees and interest. DPL provides secured and unsecured debt financing for public and private companies. These loans will typically have a six to 12-month maturity and range from $250,000-$5 million. DPL is active in bridge loans, receivable financing, inter company loans and micro loans. DPL will work with a network of company owned ATMs (terminals) in California, which will help utilize its CA Finance Lending License and enable the company to offer micro loans of up to $500 or less.

Management has over 50 years of Wall Street experience of investing in, and building companies. DPL’s desire is to bring world-class companies lending opportunities while allowing main street investors to participate. Deal flow and organization comes from an extensive network of investment bankers, business brokers, family offices, and institutional clients enabling DPL to engage and fund the most compelling companies from Silicon Valley to Wall Street.

To date, DPL has funded over $19 million in loans. Since inception, DPL has internally funded over $15 million to DPW’s portfolio companies and wholly owned subsidiaries. As for companies outside DPW, DPL has lent over $4 million in commercial and real estate loans. DPL has funded INVO Bioscience, Medovex, Parallax, Alzamend Neuro, as well as hospitality clients, such as Guilia DTLA and Prep Kitchens.

Another subsidiary wholly owned by DPW is Super Crypto Mining, Inc., a cloud computing service that provides shared and managed computing resources optimized for various block chain mining solutions. Based in Newport Beach, California, Super Crypto Mining leverages its engineering expertise and existing locations to create cryptocurrency mining facilities throughout the world. The company owns and maintains the computing resources and sells access to their use. The established mining is on the Top 3 crypto-currencies with the goal of having 10,000 miners deployed in 2018. Super Crypto Mining endeavors to leverage its engineering expertise and existing global facilities (high-security defense business locations) to secure mining farms. Super Crypto Mining is a rapidly growing organization that recently strategically secured 25 mega watts to power the company’s mining farm. For crypto currency mining, locations with inexpensive power and secure capacity are minimal and hence costly. Having such a location allows the company to grow its mining business to more than 20,000 mining machines. Super Crypto Mining continues to purchase mining machines and explore opportunities to expand its services into other related areas including mining farm real estate investments, mining machine development, and mainstream blockchain projects.

DPW additionally has beneficiary ownership in MTIX International, Inc., the parent company of MTIX, Ltd. and I.AM, Inc.

MTIX was acquired by Avalanche International aka MTIX International, Inc., in August 2017 and offers “green technology” that uses a proprietary laser process to enhance the surface of textiles. This process reduces water usage by approximately 75 percent, reduces greenhouse gases by approximately 90 percent, and reduces chemical use by approximately 95 percent.

I.AM, acquired in May 2018, owns and operates hospitality offerings that include four Prep Kitchen brand restaurants and Giulia DTLA.

Utilizing a shareholder-centric approach to compensation, DPW has formulated the following 10-year objectives:

  • Achieve compounded annual revenue growth of 25-35%
  • Achieve compounded annual net Income growth of 5%
  • Achieve positive unrestricted free cash flow by the end of 2019

DPW is led by a seasoned team of successful business professionals and entrepreneurs. The company is headquartered in Newport Beach, California.

DPW Holdings, Inc. (DPW), closed the day's trading session at $0.5126, off by 5.86%, on 2,711,950 volume with 3,707 trades. The average volume for the last 60 days is 2,114,990 and the stock's 52-week low/high is $0.4911/$5.95.

Recent News

Auscrete Corp. (OTC: ASCK)

The QualityStocks Daily Newsletter would like to spotlight Auscrete Corp. (ASCK).

Auscrete Corp. (OTC: ASCK) is a building products manufacturer of environmentally-friendly, energy-efficient housing and commercial structures using a lightweight hybrid concrete material developed through a proprietary technology.

Auscrete Corp. (OTC: ASCK) is a building products manufacturer of environmentally-friendly, energy-efficient housing and commercial structures using a lightweight hybrid concrete material developed through a proprietary technology. Auscrete’s unique process produces a medium that is cost-efficient, extremely soundproof, offers high insulation values, requires very low maintenance, won’t burn, non-toxic, highly resistant to insects and mold, and resists damage from hurricane forces and earth tremors. It’s a more affordable, energy-efficient “green” construction material that can be utilized for building residential housing and commercial structures.

Affordable homes are increasingly becoming more difficult to purchase in the U.S. with the median price of a new home consistently rising while wages stay stagnant in many areas and mortgage rates rise. The average price of new homes sold in the U.S. in 2017 was nearly $385,000, according to Statista. The homeownership rate in the U.S. has been in decline since 2004, the report states, and now amounts to a little more than 64 percent of Americans.

Auscrete’s lightweight concrete product is described as an aerated concrete material following infusion of a specially designed foaming agent during manufacture. This technology enables the product to have millions of minuscule air bubble “aggregates” introduced and evenly distributed throughout the cast sections, which creates a unique, lightweight product without compromising strength or structural integrity. Each hybrid panel also incorporates a distinctive XPS insulation amalgamation that guarantees greater comfort in a wide range of climatic conditions and a reduction in heating and cooling costs. The final product is a light and strong concrete panel with an extremely high insulation value, as well as excellent fire resistance and sound-proofing qualities.

Auscrete’s product also offers a high strength-to-weight ratio, allowing architects and engineers to develop new design and construction concepts that take advantage of the product’s reduced weight, which is nearly half that of normal concrete. Each panel can be cast in large sections, a common size being 16-feet by 8-feet, for easier transportation and faster construction on site. Savings are enhanced, not only by the energy efficiency of each panel, but through the use of mass production techniques. Auscrete estimates the company can produce a ready-to-move-in turnkey house for around $100 per square foot, which is significantly less than the 2017 median list price of $148 per square foot in the U.S., according to a report by Zillow.

Auscrete is constructing its flagship, 10-acre facility in Goldendale, Washington, on initially 5 acres the company recently purchased with the option to purchase another 5 adjacent acres. This new campus will ultimately comprise of 6 buildings, including 3 production buildings of 25,000 sq. ft. with each production buildings’ capacity of 100 homes annually, giving this flagship facility the ability to produce 300 homes or equivalent commercial structures per year.

During this construction phase, Auscrete has leased a commercial building in Goldendale. The facility will be used as a temporary headquarters and will also serve as a refurbishing station for production equipment the company has developed and used in its prior production plant. John Sprovieri, CEO and founder of Auscrete Corporation, is at the helm of the company with Mike Young serving as vice president of internal operations and Otto Paulette controlling the in-house mechanical services.

Auscrete’s Investor Relations Director, Lee Odom said, “The company’s construction process has already attracted interest from many developers, contractors and builders, some with large tracts of land looking to make available, significant numbers of Affordable Homes throughout the Country. Additionally, there have been significant commercial projects offered including 300 room destination hotel resorts, correctional facilities, a shopping complex, and a court house along with a flood of inquiries from people who are looking for more affordable building options”.

“This could really launch the commercial aspect for?ASCK, apart from residential home production which so many investors are not yet aware of,” Odom said. “A strong combination of both will lead?ASCK?to better performance through all business cycles, thus continuing to enhance the shareholder values, which is always the ultimate goal of Auscrete Corporation.”

Auscrete Corp. (ASCK), closed the day's trading session at $0.0651, off by 27.26%, on 9,694 volume with 9 trades. The average volume for the last 60 days is 123,246,275 and the stock's 52-week low/high is $0.0001/$0.10.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.